Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
14 drugs in development
By Therapeutic Area
top 6
R&D Momentum
87/100
Pipeline Velocity
58/100
Trial Completion Rate
69/100
Pipeline Concentration
28/100
Pipeline Freshness
55/100
Strategic Signals
Activity
Last 14 days
A Phase III Randomized Trial Comparing the Effects of Volume Support and Assist Control Mode Ventilation on Ventilator-Free Days and Diaphragmatic Atrophy
An Assessment of Vasoactive Medication Dose in Mechanically Ventilated Patients Undergoing Daily Sedation Awakening Trial (SAT)
Long Term Outcomes of Patients With COVID-19
Alterations of the Microbiome During Critical Illness With Short and Long Term Clinical Outcomes
Immune Resolution After Staphylococcus Aureus Bacteremia
Let's E.A.T.! (Eating With Assistive Technology): An Intervention to Support Children With Feeding Tubes and Tracheostomies
Implementation of a Triadic Network Case Management Intervention for Individuals Living With or Vulnerable to HIV
Mood Effects of Serotonin Agonists: Depression
Improving Oral Chemotherapy Adherence in Maintenance for Adolescents and Adults With Acute Lymphoblastic Leukemia and T-cell Lymphoblastic Lymphoma Using Text Messages
Oxygenation in Vascular Lesions of the Colon
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)